Academic Research Repository at the Institute of Developing Economies,Japan(ARRIDE) >
05.南アジア研究(South Asian Studies) >
04.法律、行政(Law and Public Administration)/南アジア(South Asian Studies) >

Please use this identifier to cite or link to this item: http://hdl.handle.net/2344/140

タイトル: Indian Patent Policy and Publich Health : implications from the Japanese Experience
著者: Aoki, Reiko
Kubo, Kensuke
Yamane, Hiroko
青木, 玲子
久保, 研介
山根, 裕子
キーワード: Pharmaceutical industry
Industrial policy
Intellectual property rights
Patent law
Public health
Industrial property law
Issue Date: Mar-2006
出版者: Institute of Developing Economies, JETRO
引用: IDE Discussion Paper. No. 57. 2006.3
抄録: The introduction of pharmaceutical product patents in India and other developing countries is expected to have a significant effect on public health and local pharmaceutical industries. This paper draws implications from the historical experience of Japan when it introduced product patents in 1976. In Japan, narrow patents and promotion of cross-licensing were effective tools to keep drug prices in check while ensuring the introduction of new drugs. While the global pharmaceutical market surrounding India today differs considerably from that of the 1970's, the Japanese experience offers a policy option that may profitably be considered by India today. The Indian patent system emphasizes the patentability requirement in contrast to the Japanese patent policy which relied on narrow patents and extensive licensing. R&D by local firms and the development of local products may be promoted more effectively under the Japanese model.
URI: http://hdl.handle.net/2344/140
Appears in Collections:04.IDE Discussion Paper
04.法律、行政(Law and Public Administration)/南アジア(South Asian Studies)

Files in This Item:

File Description SizeFormat
ARRIDE_Discussion_No.057_kubo.pdf191.42 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.


Privacy PolicyTerms of Use Copyright (C) JETRO. All rights reserved.